Abstract
We found a slight elevation of serum creatinine in the subjects treated with sitagliptin for 2 years and a correlation between creatinine elevation and HbA1c reduction. These results suggest that creatinine elevation is associated with activation of incretin, most possibly with up-regulation of diuretic activity of GLP-1.
Keywords:
Creatinine; Dipeptidyl peptidase-4 (DPP-4) inhibitor; HbA1c; Sitagliptin.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Publication types
-
Multicenter Study
-
Observational Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Creatinine / blood*
-
Diabetes Mellitus, Type 2 / blood*
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / ethnology
-
Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
-
Female
-
Glucagon-Like Peptide 1 / blood
-
Glycated Hemoglobin / metabolism
-
Humans
-
Japan / epidemiology
-
Male
-
Middle Aged
-
Retrospective Studies
-
Sitagliptin Phosphate / therapeutic use*
Substances
-
Dipeptidyl-Peptidase IV Inhibitors
-
Glycated Hemoglobin A
-
hemoglobin A1c protein, human
-
Glucagon-Like Peptide 1
-
Creatinine
-
Sitagliptin Phosphate